210 related articles for article (PubMed ID: 27770283)
1. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Hankinson SE; Marcantonio ER; Ngo LH
Breast Cancer Res Treat; 2016 Dec; 160(3):547-562. PubMed ID: 27770283
[TBL] [Abstract][Full Text] [Related]
2. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.
Wolfson EA; Schonberg MA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; LaCroix AZ; Chlebowski RT; Nelson RA; Ngo LH
J Natl Cancer Inst; 2024 Jan; 116(1):81-96. PubMed ID: 37676833
[TBL] [Abstract][Full Text] [Related]
3. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
[TBL] [Abstract][Full Text] [Related]
4. A model for predicting both breast cancer risk and non-breast cancer death among women > 55 years old.
Schonberg MA; Wolfson EA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; Ngo LH
Breast Cancer Res; 2023 Jan; 25(1):8. PubMed ID: 36694222
[TBL] [Abstract][Full Text] [Related]
5. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
6. Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Derks MGM; van de Velde CJH; Giardiello D; Seynaeve C; Putter H; Nortier JWR; Dirix LY; Bastiaannet E; Portielje JEA; Liefers GJ
Oncologist; 2019 Jul; 24(7):e467-e474. PubMed ID: 30606886
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
8. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract][Full Text] [Related]
9. Projecting individualized absolute invasive breast cancer risk in African American women.
Gail MH; Costantino JP; Pee D; Bondy M; Newman L; Selvan M; Anderson GL; Malone KE; Marchbanks PA; McCaskill-Stevens W; Norman SA; Simon MS; Spirtas R; Ursin G; Bernstein L
J Natl Cancer Inst; 2007 Dec; 99(23):1782-92. PubMed ID: 18042936
[TBL] [Abstract][Full Text] [Related]
10. Evaluating breast cancer risk projections for Hispanic women.
Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
[TBL] [Abstract][Full Text] [Related]
11. Prospective breast cancer risk prediction model for women undergoing screening mammography.
Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
[TBL] [Abstract][Full Text] [Related]
13. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative.
Pan K; Chlebowski RT; Mortimer JE; Gunter MJ; Rohan T; Vitolins MZ; Adams-Campbell LL; Ho GYF; Cheng TD; Nelson RA
Cancer; 2020 Aug; 126(16):3638-3647. PubMed ID: 32530506
[TBL] [Abstract][Full Text] [Related]
15. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
[TBL] [Abstract][Full Text] [Related]
16. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
Cespedes Feliciano EM; Hohensee C; Rosko AE; Anderson GL; Paskett ED; Zaslavsky O; Wallace RB; Caan BJ
JAMA Netw Open; 2020 Sep; 3(9):e2016747. PubMed ID: 32926116
[TBL] [Abstract][Full Text] [Related]
17. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
18. Association between Post-Cancer Diagnosis Dietary Inflammatory Potential and Mortality among Invasive Breast Cancer Survivors in the Women's Health Initiative.
Zheng J; Tabung FK; Zhang J; Liese AD; Shivappa N; Ockene JK; Caan B; Kroenke CH; Hébert JR; Steck SE
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):454-463. PubMed ID: 29358225
[No Abstract] [Full Text] [Related]
19. One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.
Kerlikowske K; Gard CC; Sprague BL; Tice JA; Miglioretti DL;
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):889-97. PubMed ID: 25824444
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
